Scribd
Upload
5 views3 pages

Key Financial Metrics - Onepager

Strategic Hospital Consulting LLC reports strong financial performance with a gross margin of 85.37% and a projected EBITDA of $3.93M for 2024, indicating efficient revenue generation and cost control. The company experienced a remarkable 683.1% year-over-year revenue growth, reaching $11.34M in 2024, with projections suggesting continued growth through 2026. Key buyer considerations include valuation multiples based on EBITDA and revenue, recurring revenue streams, and scalability of operations.

Uploaded by

sdas
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
5 views3 pages

Key Financial Metrics - Onepager

Strategic Hospital Consulting LLC reports strong financial performance with a gross margin of 85.37% and a projected EBITDA of $3.93M for 2024, indicating efficient revenue generation and cost control. The company experienced a remarkable 683.1% year-over-year revenue growth, reaching $11.34M in 2024, with projections suggesting continued growth through 2026. Key buyer considerations include valuation multiples based on EBITDA and revenue, recurring revenue streams, and scalability of operations.

Uploaded by

sdas
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 3

Strategic Hospital Consulting LLC.

1893, Lakewood Drive, Gaylord, Michigan 49735


PH: +1 2488049537 Email: mullins1064@gmail.com
***CONFIDENTIAL***
Key Financial Metrics

1. Gross Margin

2024: 85.37%
2023: 72.93%

Indicates a highly efficient revenue-generating device with strong cost control.

2. EBITDA Estimate

Using Operating Income as a proxy here (Depreciation & Amortization 5% Adjusted).

2024 EBITDA (adjusted): $3.93M


2023 EBITDA (approx.): $(145K)

3. EBITDA Margin
2024: 29.64%

4. YoY Revenue Growth


= ($11.34M – $1.45M) ÷ $1.45M = 683.1% growth

Explosive growth — likely commercialization phase. Due to product launch or

5. Net Margin

Formula: (Net Income ÷ Revenue) × 100


2024: 31.37%

Extremely healthy, rare in Medtech at this stage.

2025–2026 Projections (Scenario-Based)

Metric 2024 (Actual) 2025 (Base Case, +50%) 2026 (Base Case, +40%)
Revenue $11.3M $17.0M $23.8M
Gross Margin 85% 84% 83%
EBITDA Margin 30% 28% 27%
EBITDA $3.4M $4.76M $6.43M
Net Income Margin 31% 28% 26%
Net Income $3.56M $4.76M $6.19M
Strategic Hospital Consulting LLC.
1893, Lakewood Drive, Gaylord, Michigan 49735
PH: +1 2488049537 Email: mullins1064@gmail.com
***CONFIDENTIAL***
These are moderate-growth assumptions. A high-growth case could double 2025 revenue again
depending on expansion and funding.

Summary of Income Statement (Accrual Basis)

2024 2023
Metric
Total Revenue $11,338,429 $1,447,856
COGS $1,662,033 $392,208
Gross Profit $9,676,396 $1,055,648
Operating Expenses $6,315,544 $1,200,893
Net Operating Income $3,360,852 $(145,245)
Other Income (Net) $197,421 $(44,103)
Net Income $3,558,273 $(189,348)

Gross Margin: Highly efficient revenue-generating device with strong cost control.
2024: 85.37%
2023: 72.93%

Financial Projections (2024–2026)

Chart 1: Revenue, EBITDA, and Net Income

Year Revenue ($M) EBITDA ($M) Net Income ($M)


2024 (Actual) 11.3 3.4 3.56
2025 (Est.) 17.0 4.76 4.76

Buyer Considerations:

 Valuation Multiple Basis: Apply 5–8x EBITDA or 3–6x Revenue, depending on growth
profile, IP defensibility, and clinical traction.
 Recurring Revenue: Enhances predictability — service + consumables appear as high-
margin recurring streams.
 Scalability: OPEX structure supports increased scale without proportional increase in
cost.
Strategic Hospital Consulting LLC.
1893, Lakewood Drive, Gaylord, Michigan 49735
PH: +1 2488049537 Email: mullins1064@gmail.com
***CONFIDENTIAL***

You might also like